Access to antiviral therapy for chronic hepatitis B during COVID-19.

Marilia Rocha Bertolli Priscilla Alves Rocha Vanusa Barbosa Pinto Suzane Kioko Ono

Published in: Revista da Associacao Medica Brasileira (1992) (2022)

This study contributes to the rationalization of efforts in a public health crisis through the identification of groups with the highest risk of poor access to antiviral therapy and the demonstration of the benefits of a medication delivery system.

Keyphrases

public health
hepatitis b virus
global health
adverse drug
bone marrow
bioinformatics analysis